The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Open accessAbstract
Deposition of amyloid β protein (Aβ) to form neuritic plaques in the brain is the pathological hallmark of Alzheimer's disease (AD). Aβ is generated from sequential cleavages of the β-amyloid precursor protein (APP) by the β- and γ-secretases, and β-site APP-cleaving enzyme 1 (BACE1) is the β-secretase essential for Aβ generation. Previous studies have indicated that glycogen synthase kinase 3 (GSK3) may play a role in APP processing by modulating γ-secretase activity, thereby facilitating Aβ production. There are two highly conserved isoforms of GSK3: GSK3α and GSK3β. We now report that specific inhibition of GSK3β, but not GSK3α, reduced BACE1-mediated cleavage of APP and Aβ production by decreasing BACE1 gene transcription and expression. The regulation of BACE1 gene expression by GSK3β was dependent on NF-κB signaling. Inhibition of GSK3 signaling markedly reduced Aβ deposition and neuritic plaque formation, and rescued memory deficits in the double transgenic AD model mice. These data provide evidence for regulation of BACE1 expression and AD pathogenesis by GSK3β and that inhibition of GSK3 signaling can reduce Aβ neuropathology and alleviate memory deficits in AD model mice. Our study suggests that interventions that specifically target the β-isoform of GSK3 may be a safe and effective approach for treating AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“GSK3β is already known to be involved in the regulation of APP metabolism, Tau phosphorylation and synaptic functions41–43, making it a potential link between PLCγ2 and the different phenotypes associated with its downregulation.”
From PLCG2 downregulation impairs synaptic function and increases Alzheimer’s disease hallmarks in neuronal cultures (2026) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · cited 1×
“Many of the Wnt signal transduction components such as the APC gene or β-catenin gene carry mutations that render the protein nondegradable (94).”
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Self-citationNeurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Purification and cloning of amyloid precursor protein β-secretase from human brain
Sinha, S., Anderson, J. P., Barbour, R., Basi, G. S., Caccavello, R., Davis, D., Doan, M., Dovey, H. F., Frigon, N., Hong, J., et al. (1999) · Nature · doi:10.1038/990114 · Cited by 1,612
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438
Research works printed but not linked: 3
- Ly, 2011, J Vis Exp., 2831
- Bromley-Brits, 2011, J Vis Exp., 2920
- Wyss-Coray, 2006, Nat Med., 12, 1005
Cited by
Sorted by citations
Items 101–200 of 446
Sambon, M., Wins, P., & Bettendorff, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115418 · Cited by 69
Mitochondria in Alzheimer’s Disease Pathogenesis
Reiss, A. B., Gulkarov, S., Jacob, B., Srivastava, A., Pinkhasov, A., Gomolin, I. H., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2024) · Life · doi:10.3390/life14020196 · Cited by 71
Zhang, H., Peng, J., Cheng, X.-B., Shi, B., Zhang, M., & Xu, R. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1632-z · Cited by 62
Self-citationAmyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling
Lee, I.-S., Jung, K., Kim, I., & Park, K. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.125 · Cited by 63
Wu, Y., Lü, Z., Li, Y., Yang, J., & Zhang, X. (2020) · Nanomaterials · doi:10.3390/nano10081441 · Cited by 63
Self-citationAlireza, M. S., Nikbakht, F., Nia, H. H., Golab, F., Khadem, Y., Barati, M., & Vazifekhah, S. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102200 · Cited by 61
Protective effects of evodiamine in experimental paradigm of Alzheimer’s disease
Wang, D., Wang, C., Liu, L., & Li, S. (2018) · Cognitive Neurodynamics · doi:10.1007/s11571-017-9471-z · Cited by 60
Huang, W., Chen, P., Yu, K., Han, Y., Song, M., & Li, Y. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.114 · Cited by 59
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects
Cheng, Z., Han, T., Yao, J., Wang, K., Dong, X., Fan, Y., Huang, H., Han, M., Liao, Q., He, S., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116065 · Cited by 58
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Gianferrara, T., Cescon, E., Grieco, I., Spalluto, G., & Federico, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220216113517 · Cited by 58
Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology
Kolisnyk, B., Al‐Onaizi, M., Soreq, L., Barbash, S., Bekenstein, U., Haberman, N., Hanin, G., Kish, M. T., da Silva, J. S., Fahnestock, M. L., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw177 · Cited by 56
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation
Cao, J., Tyburczy, M. E., Moss, J., Darling, T. N., Widlund, H. R., & Kwiatkowski, D. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84262 · Cited by 57
Wilson, E. N., Do Carmo, S., Iulita, M. F., Hall, H., Ducatenzeiler, A., Marks, A. R., Allard, S., Jia, D. T., Windheim, J., & Cuello, A. C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.169 · Cited by 56
Shehata, M. K., Ismail, A. A., & Kamel, M. A. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s417928 · Cited by 55
Han, T., Qin, Y., Mou, C., Wang, M., Jiang, M., & Liu, B. (2016) · PubMed Central · Cited by 55
MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation
Zhu, B., Long, Y., Luo, W., Yan, Z., Lai, Y., Zhao, L., Zhou, W., Wang, Y., Shen, L., Liu, L., et al. (2018) · Brain · doi:10.1093/brain/awy305 · Cited by 53
Self-citationLong-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice
Stagni, F., Giacomini, A., Guidi, S., Ciani, E., Ragazzi, E., Filonzi, M., IASIO, R. D., Rimondini, R., & Bartesaghi, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.005 · Cited by 55
Shang, J., Yamashita, T., Tian, F., Li, X., Liu, X., Shi, X., Nakano, Y., Tsunoda, K., Nomura, E., Sasaki, R., et al. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146379 · Cited by 55
Tau acts as a mediator forAlzheimer's disease‐related synaptic deficits
Liao, D., Miller, E. C., & Teravskis, P. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12504 · Cited by 53
Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Agarwal, M., Alam, R., Haider, M. K., Malik, M. Z., & Kim, D.-K. (2020) · Nanomaterials · doi:10.3390/nano11010059 · Cited by 59
The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease
Liew, A. K. Y., Teo, C. H., & Soga, T. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03016-w · Cited by 61
Wang, X., Yu, S., Hu, J.-P., Wang, C., Wang, Y., Liu, H.-X., & Liu, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.866110 · Cited by 55
RCAN1 Overexpression Exacerbates Calcium Overloading-Induced Neuronal Apoptosis
Sun, X., Wu, Y., Herculano, B., & Song, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095471 · Cited by 52
Self-citationTan, X., Liang, Z., Li, Y., Zhi, Y., Yi, L., Bai, S., Forest, K. H., Nichols, R. A., Dong, Y., & Li, Q. X. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112968 · Cited by 52
Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
Zagórska, A., & Jaromin, A. (2020) · Molecules · doi:10.3390/molecules25153337 · Cited by 51
Alexander, C., Parsaee, A., & Vasefi, M. (2023) · Biology · doi:10.3390/biology12111453 · Cited by 52
Hypoxia Signaling Regulates Macrophage Migration Inhibitory Factor (MIF) Expression in Stroke
Zis, O., Zhang, S., Dorovini‐Zis, K., Wang, L., & Song, W. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8727-4 · Cited by 52
Self-citationEstrogen-related receptor alpha is involved in Alzheimer's disease-like pathology
Tang, Y., Min, Z., Xiang, X., Liu, L., Ma, Y., Zhu, B., Li, S., Tang, J., Deng, X., Yan, Z., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.04.003 · Cited by 51
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014) · Oncoscience · doi:10.18632/oncoscience.64 · Cited by 50
Liu, W., Liu, X., Liu, W., Gao, Y., Wu, L., Huang, Y., Chen, H., Li, D., Zhou, L., Wang, N., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114095 · Cited by 52
New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease
Medina, M., & Ávila, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.843670 · Cited by 50
β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3
Deng, Y., Zhe, X., Chen, P., Wei, J., Chen, S., & Yan, Z. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.031 · Cited by 53
Wen, M., Xu, J., Ding, L., Zhang, L., Du, L., Wang, J., Wang, Y., & Xue, C. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.04.034 · Cited by 50
El-Ganainy, S. O., Soliman, O., Ghazy, A. A., Allam, M., Elbahnasi, A. I., Mansour, A. M., & Gowayed, M. A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03624-x · Cited by 49
Freese, C., Reinhardt, S., Hefner, G., Unger, R. E., Kirkpatrick, C. J., & Endres, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091003 · Cited by 49
Meng, L., Li, X., Shen, L., & Ji, H. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.02.002 · Cited by 49
Down‐regulation of MIF by NFκB under hypoxia accelerated neuronal loss during stroke
Zhang, S., Zis, O., Ly, P. T. T., Wu, Y., Zhang, S., Zhang, M., Cai, F., Bucala, R., Shyu, W., & Song, W. (2014) · The FASEB Journal · doi:10.1096/fj.14-253625 · Cited by 50
Self-citationKoh, E.-J., Kim, K.-J., Song, J.-H., Choi, J., Lee, H., Kang, D.-H., Heo, H., & Lee, B.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112401 · Cited by 48
Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors
Evin, G. M. (2016) · BioDrugs · doi:10.1007/s40259-016-0168-3 · Cited by 52
Degradation of FA reduces Aβ neurotoxicity and Alzheimer-related phenotypes
Fei, X., Zhang, Y., Mei, Y., Yue, X., Jiang, W., Ai, L., Yu, Y., Luo, H., Li, H., Luo, W., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00929-7 · Cited by 48
Self-citationMansour, H. M., Fawzy, H. M., El-Khatib, A. S., & Khattab, M. M. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113697 · Cited by 49
Fronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 47
The rise and fall of insulin signaling in Alzheimer’s disease
Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48
GSK-3β deletion in dentate gyrus excitatory neuron impairs synaptic plasticity and memory
Liu, E., Xie, A., Zhou, Q., Li, M., Zhang, S., Li, S., Wang, W., Wang, X., Wang, Q., & Wang, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-06173-4 · Cited by 48
Zong, W., Zeng, X., Chen, S., Chen, L., Zhou, L., Wang, X., Gao, Q., Zeng, G., Hu, K., & Ouyang, D. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.01.013 · Cited by 48
Glycogen synthase kinase-3 as a key regulator of cognitive function
Fan, X., Zhao, Z., Wang, D., & Xiao, J. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz156 · Cited by 50
Machine Learning for Discovery of GSK3β Inhibitors
Vignaux, P. A., Minerali, E., Foil, D. H., Puhl, A. C., & Ekins, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c03302 · Cited by 49
Gupta, S. N., Singh, V., Ganesh, S., Singhal, N. K., & Sandhir, R. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c15305 · Cited by 46
The Role of 6-Gingerol on Inhibiting Amyloid β Protein-Induced Apoptosis in PC12 Cells
Zeng, G., Zong, S., Zhang, Z., Fu, S.-W., Li, K.-K., Fang, Y., Lü, L., & Xiao, D.-Q. (2015) · Rejuvenation Research · doi:10.1089/rej.2014.1657 · Cited by 48
Sidiropoulou, G. A., Metaxas, A., & Kourti, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217730 · Cited by 54
Shukla, M., & Vincent, B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101062 · Cited by 52
Rodríguez, M. H., Arciniega-Martínez, I. M., García-Marín, I. D., Correa‐Basurto, J., & Rosales‐Hernández, M. C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02009-x · Cited by 51
Dieckol Ameliorates Aβ Production via PI3K/Akt/GSK-3β Regulated APP Processing in SweAPP N2a Cell
Yoon, J.-H., Lee, N., Youn, K., Jo, M. R., Kim, H., Lee, D., Ho, C., & Jun, M. (2021) · Marine Drugs · doi:10.3390/md19030152 · Cited by 46
Maurya, S. K., Mishra, J., Abbas, S., & Bandyopadhyay, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9061-6 · Cited by 46
Sun, C., Zhang, X.-Y., Zhou, J., Huo, X., Yu, Z., Morisseau, C. H. P., Hammock, B. D., & Ma, X. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112516 · Cited by 43
Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology
Su, M., Nadéri, K., Samson-Desvignes, N., Youssef, I., Fülöp, L., Bozsó, Z., Laroche, S., Delatour, B., & Davis, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1475-8 · Cited by 42
Norwitz, N. G., Soto-Mota, A., Norwitz, S. G., & Clarke, K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00184 · Cited by 42
Trehalose Inhibits Aβ Generation and Plaque Formation in Alzheimer’s Disease
Liu, Y., Wang, J., Hsiung, G. R., & Song, W. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01942-1 · Cited by 43
Self-citationOrejana, L., Barros-Miñones, L., Jordán, J., Cedazo-Mı́nguez, Á., Tordera, R. M., Aguirre, N., & Puerta, E. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu106 · Cited by 42
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 43
Wu, Y., Ly, P. T. T., & Song, W. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8704-y · Cited by 40
Self-citationMaurin, H., Lechat, B., Dewachter, I., Ris, L., Louis, J. V., Borghgraef, P., Devijver, H., Jaworski, T., & LEUVEN, F. V. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-27 · Cited by 39
Regulation of global gene expression and cell proliferation by APP
Wu, Y., Zhang, S., Xu, Q., Zou, H., Zhou, W., Cai, F., Li, T., & Song, W. (2016) · Scientific Reports · doi:10.1038/srep22460 · Cited by 41
Self-citationWang, S., Jiang, Y. X., Liu, Y., Liu, Q., Sun, H., Mei, M., & Liao, X. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02731-8 · Cited by 40
Shen, Y., Zhao, M., Zhao, P., Meng, L., Zhang, Y., Zhang, G., Taishi, Y., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1408462 · Cited by 45
Chen, J., Long, Z., Li, Y., Luo, M., Luo, S., & He, G. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4198 · Cited by 42
Targeting CaN/NFAT in Alzheimer’s brain degeneration
Mackiewicz, J., Lisek, M., & Boczek, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281882 · Cited by 41
Wu, Y., Deng, Y., Zhang, S., Luo, Y., Cai, F., Zhang, Z., Zhou, W., Li, T., & Song, W. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.029 · Cited by 39
Self-citationSalvianolic Acid B Inhibits Aβ Generation by Modulating BACE1 Activity in SH-SY5Y-APPsw Cells
Tang, Y. C., Huang, D., Zhang, M., Zhang, W., Tang, Y., Shi, Z.-X., Deng, L., Zhou, D.-H., & Lu, X. (2016) · Nutrients · doi:10.3390/nu8060333 · Cited by 38
Self-citationDu, Y., Liu, X., Zhu, X., Liu, Y. M., Wang, X., & Wu, X. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1715977 · Cited by 38
Zeng, P. H., Su, H.-F., Ye, C., Qiu, S.-W., & Tian, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.806984 · Cited by 37
Bian, X., Yang, L., Jiang, D., Grippin, A., Ma, Y., Wu, S., Wu, L., Wang, X., Tang, Z., Tang, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48461-4 · Cited by 41
Varamini, B., Sikalidis, A. K., & Bradford, K. L. (2013) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2013.832171 · Cited by 38
Connexins and pannexins in Alzheimer’s disease
Giaume, C., Sáez, J. C., Song, W., Leybaert, L., & Naus, C. C. G. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.006 · Cited by 40
Self-citationStagni, F., & Bartesaghi, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.903729 · Cited by 33
The Role of Insulin Signaling in Hippocampal-Related Diseases: A Focus on Alzheimer’s Disease
Liu, Q., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214417 · Cited by 42
Regulator of calcineurin 1 is a novel RNA-binding protein to regulate neuronal apoptosis
Yun, Y., Zhang, Y., Zhang, C., Huang, L., Tan, S., Wang, P., Vilariño‐Güell, C., Song, W., & Sun, X. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0487-0 · Cited by 36
Self-citationLiu, X., Wang, K., Wei, X., Xie, T., Lv, B., Zhou, Q., & Wang, X. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03227-y · Cited by 37
Wang, S., & Qi, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.916653 · Cited by 39
Melatonin attenuates streptozotocin-induced Alzheimer-like features in hyperglycemic rats
Kamsrijai, U., Wongchitrat, P., Nopparat, C., Satayavivad, J., & Govitrapong, P. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104601 · Cited by 37
Role of aluminum exposure on Alzheimer’s disease and related glycogen synthase kinase pathway
Sanajou, S., Erkekoğlu, P., Şahin, G., & Baydar, T. (2022) · Drug and Chemical Toxicology · doi:10.1080/01480545.2022.2065291 · Cited by 36
Rajasekar, N., Nath, C., Hanif, K., & Shukla, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9576-5 · Cited by 36
Machine learning in Alzheimer’s disease drug discovery and target identification
Geng, C., Wang, Z., & Tang, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102172 · Cited by 34
Cdc42GAP deficiency contributes to the Alzheimer’s disease phenotype
Zhu, M., Xiao, B., Xue, T., Qin, S., Ding, J., Wu, Y. H., Tang, Q., Huang, M., Zhao, N., Ye, Y., et al. (2023) · Brain · doi:10.1093/brain/awad184 · Cited by 32
Self-citationMild traumatic brain injury induces memory deficits with alteration of gene expression profile
Luo, Y., Zou, H., Wu, Y., Cai, F., Zhang, S., & Song, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-11458-9 · Cited by 32
Self-citationSaleh, R. A., Eissa, T. F., Abdallah, D. M., Saad, M. A., & El-Abhar, H. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-90545-4 · Cited by 36
Baranowski, B. J., Mohammad, A., Finch, M. S., Brown, A. D. H., Dhaliwal, R., Marko, D. M., LeBlanc, P. J., McCormick, C. M., Fajardo, V. A., & MacPherson, R. E. K. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00114.2023 · Cited by 36
Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated Pathways
Martins, W. C., Tasca, C. I., & Cimarosti, H. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1681-3 · Cited by 32
Chew, B., Ryu, J. R., Ng, T., Ma, D., Dasgupta, A., Neo, S. H., Zhao, J., Zhong, Z., Bichler, Z., Sajikumar, S., et al. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00158 · Cited by 32
Huang, H.-J., Chen, S.-L., Chang, Y.-T., Chyuan, J., & Hsieh‐Li, H. M. (2018) · Nutrients · doi:10.3390/nu10121888 · Cited by 31
Heider, F., Ansideri, F., Tesch, R., Pantsar, T., Haun, U., Döring, E., Kudolo, M., Poso, A., Albrecht, W., Laufer, S., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.035 · Cited by 31
On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer’s Disease
Kriška, J., Heřmanová, Z., Knotek, T., Turečková, J., & Anděrová, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189689 · Cited by 33
Medina, M., & Ávila, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.39 · Cited by 33
Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats
Ali, A. A., Ahmed, H. I., Khaleel, S. A., & Abu‐Elfotuh, K. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112571 · Cited by 31
Xiang, L., Wang, Y., Liu, S., Liu, B., Jin, X., & Cao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411275 · Cited by 32
Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer’s Disease
Sequeira, R. C., & Godad, A. P. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03839-1 · Cited by 31
Kim, H. J., Joe, Y., Chen, Y., Park, G. H., Kim, U., & Chung, H. (2018) · Aging Cell · doi:10.1111/acel.12864 · Cited by 32
APP-Mediated Signaling Prevents Memory Decline in Alzheimer’s Disease Mouse Model
Deyts, C., Clutter, M., Pierce, N., Chakrabarty, P., Ladd, T. B., GODDI, A. A., Rosario, A. M., Cruz, P. E., Vetrivel, K. S., Wagner, S. L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.087 · Cited by 31
Microglia and its Genetics in Alzheimer's Disease
Liang, X., Wu, H., Colt, M., Guo, X., Pluimer, B. R., Zeng, J., Dong, S., & Zhao, Z. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211105140732 · Cited by 32
Metadata
- Authors
- Ly, P. T. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., & Song, W.
- Affiliations
- University of British Columbia (CA)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Kyoto University (JP)
- Corresponding author
- Song, Weihong
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-12-03
- Volume
- 123
- Issue
- 1
- Pages
- 224-235
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3533290
- OpenAlex
- W2168597028
- Cited by
- 442
- References
- 105
- Citations by year
- 2026: 32 · 2025: 50 · 2024: 43 · 2023: 46 · 2022: 34 · 2021: 36 · 2020: 29 · 2019: 30 · 2018: 20 · 2017: 27 · 2016: 21 · 2015: 21 · 2014: 34 · 2013: 19
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Michael Smith Health Research BC
- National Natural Science Foundation of China
- Canadian Institutes of Health Research (117948_1, 97825_1)
- Natural Sciences and Engineering Research Council of Canada
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, GSK3β, BACE1, amyloid-beta, APP processing, beta-secretase, gamma-secretase, NF-κB signaling, neuritic plaques, memory impairment, GSK3 inhibition, transcriptional regulation
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Disease Models, Animal, Enzyme Activation, Humans, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Enzymologic, Aspartic Acid Endopeptidases, NF-kappa B, Amyloid beta-Protein Precursor, Mice, Knockout, Glycogen Synthase Kinase 3, Mice, Amyloid Precursor Protein Secretases, HEK293 Cells, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
